Dutch Biotech Event

28/06/19

To go directly to registration, click here.

HollandBIO’s annual Dutch Biotech Event will return to Maarssen on Friday June 28. Whether you’re working at a biotech startup, scale-up, runner-up or an established multinational, you do not want to miss out on this event. Be inspired by life sciences innovations, learn from serial entrepreneurs, meet experts to boost your company’s performance, and upgrade your personal and professional skills. Click here for the full program of the Dutch Biotech Event 2019. 

Program

We are proud to announce the keynote speakers:

• Arie Belldegrun, M.D., FACS, is the Executive Chairman and Co-Founder of Allogene. He currently serves as Chairman of Two River Group, UroGen Pharma and Kronos Bio. He is a Co-Founder and Senior Managing Director of Vida Ventures. In 2009, Arie founded Kite Pharma, a biopharmaceutical company engaged in the development of innovative cancer immunotherapies, where he served as Chairman, President and Chief Executive Officer until the acquisition of Kite by Gilead Sciences in October 2017.
• John Haurum is an experienced biotech leader and former CEO of F-Star Biotechnology. After obtaining his PhD from the University of Oxford, his successful biotech career started back in 2000 as a co-founder of his first company Symphogen, a Danish clinical-stage antibody oncology-focused company. Currently John serves as a board member in several biotech companies. Most recently he became chairman of AgomAb Therapeutics, a privately held Belgian biotherapeutics company developing agonistic antibodies for regeneration of damaged tissues.
• Tim Knotnerus has 10 years of progressively responsible experience in the biotech and venture capital industries. Prior to AgomAb Therapeutics, Tim was VP Corporate Development at AM-Pharma where he was responsible for Corporate and Business Development of the company. In that capacity he co-led the $600M option-to-acquisition deal between Pfizer and AM-Pharma. Prior to that, Tim was a senior associate at Aescap Venture, a venture capital fund investing in European medical companies, where he was instrumental in the financing and support of various portfolio companies.

Workshop speakers include:
Edward van Wezel (BGV), Erik van den Berg (AM-Pharma), Guus Scheefhals (DegenRx), Hugo van Rooijen (Janssen Pharmaceuticals), Jos Seegers (MyMicroZoo), Peter van de Sande (Synaffix), Rudolf van Olden (Avexis), Tjarda
Kasteel (bluebird bio), Wim de Laat (FunGenX), Ypke van Oosterhout (Xenikos)

Be sure to expect a great line-up of biotech entrepreneurs and interactive workshops. Of course, the program offers plenty of opportunity to catch up with your peers. The Dutch Biotech Event welcomes biotech companies of all sizes, from start-ups to multinationals.

Practical information

Date: Friday June 28th
Time: 13.00 – 20.00hr including BBQ
Location: Inn Style, Herenweg 55 Maarssen
Registration: The Dutch Biotech Event 2019 welcomes biotech companies of all sizes, from start-up to multinational. Not a biotech company nor a HollandBIO member? Please contact HollandBIO to discuss the possibilities to attend the event.

HollandBIO members attend the event free of charge, the registration fee for non-members is € 150,- excl. VAT. For registration, click here.

You’ll find more information about the HollandBIO Membership at our website.

The Dutch Biotech Event 2019 is made possible by: